A69T (p.Ala69Thr) variant of CD2 (T-cell surface antigen CD2)

A69T (p.Ala69Thr) in CD2 (T-cell surface antigen CD2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.23 / 1. The record also includes population frequency data and structural context.

A69T (p.Ala69Thr) variant details